Mercator Medical S.A.
MRC.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | 0.23 | 0.02 | -0.04 |
| FCF Yield | -20.23% | -9.84% | -14.28% | 33.23% |
| EV / EBITDA | -70.13 | -3.61 | -1.64 | 1.30 |
| Quality | ||||
| ROIC | 3.91% | -59.10% | -18.13% | 37.30% |
| Gross Margin | 26.00% | 21.92% | 16.28% | 39.59% |
| Cash Conversion Ratio | -1.41 | 0.00 | -0.22 | 1.13 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.01% | -35.24% | -33.37% | 47.31% |
| Free Cash Flow Growth | -131.86% | 43.14% | -121.11% | -53.19% |
| Safety | ||||
| Net Debt / EBITDA | 25.18 | 4.12 | 1.38 | -0.67 |
| Interest Coverage | 76.05 | -104.71 | -227.09 | 850.34 |
| Efficiency | ||||
| Inventory Turnover | 1.87 | 2.91 | 2.22 | 4.12 |
| Cash Conversion Cycle | 186.63 | 162.66 | 182.55 | 94.97 |